Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Ehlers-Danlos Syndrome Clinical Trials
Ehlers-Danlos Syndrome clinical trials are recruiting across 20 cities. Here are the cities with the most active studies:
Ehlers-Danlos Syndrome Trial Phases
11 research organizations are sponsoring ehlers-danlos syndrome trials.
About Ehlers-Danlos Syndrome
Ehlers-Danlos syndrome is a group of inherited disorders affecting connective tissues that provide support to skin, bones, blood vessels, and organs. Symptoms include overly flexible joints and stretchy, fragile skin. Treatment focuses on managing symptoms and preventing complications.
Clinical trials are advancing new treatments for ehlers-danlos syndrome. Currently, 11 studies are recruiting a combined 4,045 participants across the United States. Research is being conducted by 11 organizations including State University of New York at Buffalo, Stony Brook University, NYU Langone Health and 8 others.
2026 Ehlers-Danlos Syndrome Research Landscape
As of July 2026, the ehlers-danlos syndrome clinical trial landscape includes 11 actively recruiting studies across 20 cities in the United States. These studies are collectively seeking 4,045 participants, with an average enrollment target of 368 per study.
The research spans multiple phases of development: 6 studies are in NA, 2 studies are in PHASE3. The presence of Phase 3 trials indicates that some ehlers-danlos syndrome treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 11 different organizations, including State University of New York at Buffalo, Stony Brook University, NYU Langone Health, Harmony Biosciences Management, Inc., Memorial Sloan Kettering Cancer Center, and 6 others. The large number of sponsors reflects significant research interest and investment in ehlers-danlos syndrome treatment advancement.
Geographically, ehlers-danlos syndrome trials are most concentrated in New York, New York (3 trials); Buffalo, New York (1 trial); Middleport, New York (1 trial); Niagara Falls, New York (1 trial); Peoria, Arizona (1 trial) and 7 other cities.
Featured Ehlers-Danlos Syndrome Studies
Highlighted recruiting studies for ehlers-danlos syndrome, selected by enrollment size and research scope.
Community Pharmacies as Social Determinant of Health Navigators
Type 1 hybrid effectiveness-implementation study using a quasi-experimental, difference-in-difference (DID) design to deliver a comprehensive social needs screening and navigation program by integrating Community Health Workers (CHWs) into community pharmacies across under-resourced areas in Western New York (WNY).
Addressing Durable Health Disparities Through Critical Time Legal Interventions in Medically Underserved Latinx and Migrant Communities
This clinical trial will examine the effects of legal services on primary care outcomes for medically underserved communities. The aims of the study are: 1. To test the effectiveness and cost-benefits of a critical-time intervention Medical-Legal Partnership (CTI-MLP) on patient outcomes. 2. To determine the most efficient mechanisms for CTI-MLP delivery. 3. To develop innovative community engag...
Catch A Vibe - 24-00864
This study evaluates a proposed community-based implementation strategy to scale up screening, identification, and intervention on Health-Related Social Needs (HRSN) among persons on Long-Acting Injectable Pre-exposure Prophylaxis (LAI-PrEP). To do so, (1) screening for HRSN will occur at provider visits every 4 months, (2) navigation and establishment of connections with community resources throu...
Frequently Asked Questions About Ehlers-Danlos Syndrome Clinical Trials
Are there ehlers-danlos syndrome clinical trials near me?
Yes, there are 11 ehlers-danlos syndrome clinical trials currently recruiting across 20+ cities in the United States, including New York, New York; Buffalo, New York; Middleport, New York. Browse the studies above to find one at a location convenient for you.
How do I join a ehlers-danlos syndrome clinical trial?
To join a ehlers-danlos syndrome clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are ehlers-danlos syndrome clinical trials free?
Yes, participation in ehlers-danlos syndrome clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of ehlers-danlos syndrome treatments are being studied?
Current ehlers-danlos syndrome clinical trials are testing a range of approaches across NA (6 studies), PHASE3 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 11 research organizations.
Is it safe to participate in ehlers-danlos syndrome clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 15, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 15, 2026 · Data from ClinicalTrials.gov